Trupanion, Inc. (NASDAQ:TRUP) CFO Sells $37,698.84 in Stock

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CFO Fawwad Qureshi sold 828 shares of the stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $45.53, for a total value of $37,698.84. Following the completion of the transaction, the chief financial officer now owns 6,079 shares in the company, valued at $276,776.87. This represents a 11.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Fawwad Qureshi also recently made the following trade(s):

• On Thursday, May 29th, Fawwad Qureshi sold 2,534 shares of Trupanion stock. The shares were sold at an average price of $48.31, for a total transaction of $122,417.54.

Trupanion Stock Performance

Shares of Trupanion stock traded up $1.81 on Tuesday, reaching $48.54. The stock had a trading volume of 257,445 shares, compared to its average volume of 608,371. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The business's 50-day moving average price is $40.08 and its two-hundred day moving average price is $43.76. The stock has a market cap of $2.08 billion, a P/E ratio of -211.04, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. Trupanion, Inc. has a fifty-two week low of $25.90 and a fifty-two week high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.05) by $0.02. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm had revenue of $341.98 million for the quarter, compared to the consensus estimate of $337.81 million. During the same quarter last year, the firm posted ($0.16) EPS. The business's quarterly revenue was up 11.7% on a year-over-year basis. On average, sell-side analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.

Hedge Funds Weigh In On Trupanion

Several large investors have recently made changes to their positions in TRUP. Bayforest Capital Ltd grew its holdings in Trupanion by 627.4% in the 1st quarter. Bayforest Capital Ltd now owns 28,457 shares of the financial services provider's stock valued at $1,061,000 after buying an additional 24,545 shares during the last quarter. Millennium Management LLC grew its stake in shares of Trupanion by 73.5% in the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider's stock worth $9,987,000 after acquiring an additional 113,490 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Trupanion by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider's stock worth $731,000 after acquiring an additional 858 shares during the period. Jacobs Levy Equity Management Inc. increased its position in Trupanion by 2,029.0% during the first quarter. Jacobs Levy Equity Management Inc. now owns 303,550 shares of the financial services provider's stock worth $11,313,000 after acquiring an additional 289,292 shares during the period. Finally, PDT Partners LLC raised its stake in Trupanion by 346.2% during the 1st quarter. PDT Partners LLC now owns 136,110 shares of the financial services provider's stock valued at $5,073,000 after purchasing an additional 105,605 shares during the last quarter.

Analyst Ratings Changes

A number of research firms have recently weighed in on TRUP. Lake Street Capital cut their price target on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a report on Friday, May 2nd. Piper Sandler lowered their target price on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Finally, Stifel Nicolaus cut their target price on Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $51.80.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.